Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

JANX

Janux Therapeutics Inc

May 22 • 04:00PM ET

14.52

+0.11 0.76 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS ALLO IOVA KYMR NRIX

| Held by: XBI VTI IWM VXF IBB IWN SCHA VTWO VHT IWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.84	Insider Own	6.83%	Shs Outstand	60.87M	Perf Week	4.54%
Market Cap	885.49M	Forward P/E	-	EPS next Y	-2.74	Insider Trans	-0.58%	Shs Float	56.82M	Perf Month	-4.41%
Enterprise Value	-49.33M	PEG	-	EPS next Q	-0.31	Inst Own	96.61%	Short Float	13.96%	Perf Quarter	8.60%
Income	-114.48M	P/S	64.49	EPS this Y	-2.60%	Inst Trans	-6.59%	Short Ratio	7.61	Perf Half Y	-49.60%
Sales	13.73M	P/B	0.94	EPS next Y	-46.16%	ROA	-11.01%	Short Interest	7.93M	Perf YTD	5.22%
Book/sh	15.47	P/C	0.93	EPS next 5Y	-22.59%	ROE	-11.72%	52W High	35.34 -58.91%	Perf Year	-42.40%
Cash/sh	15.68	P/FCF	-	EPS past 3/5Y	-6.44% -62.26%	ROIC	-11.92%	52W Low	12.12 19.80%	Perf 3Y	7.32%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.11% -	Gross Margin	85.59%	Volatility	3.73% 3.95%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-3.59	EPS Y/Y TTM	-35.51%	Oper. Margin	-1143.11%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.01	Sales Y/Y TTM	47.10%	Profit Margin	-833.60%	RSI (14)	51.55	Recom	1.58
Dividend Gr. 3/5Y	- -	Current Ratio	17.01	EPS Q/Q	-2.21%	SMA20	1.07%	Beta	2.55	Target Price	40.35
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	0.52%	Rel Volume	0.42	Prev Close	14.41
Employees	109	LT Debt/Eq	0.02	Earnings	May 07 AMC	SMA200	-23.35%	Avg Volume	1.04M	Price	14.52
IPO	Jun 11, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.17% -14.10%	Trades		Volume	436,397	Change	0.76%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)